CCC
JBIO

Cable Car Capital’s Jade Biosciences JBIO Stock Holding History

Cable Car Capital’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,851
Closed -$1.48M – 68
2025
Q1 		$1.48M Buy
+16,851
New +$1.48M 1.68% 21

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Cable Car Capital's JBIO Position: Q2 2025 in Review

Cable Car Capital sold out of Jade Biosciences (JBIO) in Q2 2025, closing a stake of 16,851 shares — an estimated $1.48M sold.

Cable Car Capital first reported a position in JBIO in Q1 2025 and held it in 1 quarter. The position peaked at $1.48M in Q1 2025. 75 funds tracked by Wall St. Rank hold JBIO as of Q2 2025.

  • Cable Car Capital reported no remaining Jade Biosciences position as of Q2 2025 after selling out during the quarter.
  • Cable Car Capital sold 16,851 Jade Biosciences shares in Q2 2025, an estimated $1.48M.
  • Cable Car Capital first reported a position in Jade Biosciences in Q1 2025 and held it in 1 quarter.
  • Cable Car Capital's Jade Biosciences position peaked at $1.48M in Q1 2025.
  • 75 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2025.

Based on Cable Car Capital's 13F filing for Q2 2025, filed 14 Aug 2025.